Participants
| Role | Name | HCID | Charge |
|---|
| Reactant | Methyl iodide | HCID 6328 | — |
| Reactant | Sodium hydride | HCID 24758 | — |
| Reactant | Sodium Bicarbonate | HCID 516892 | — |
| Reactant | HCID 23109904 | HCID 23109904 | — |
| Solvent | Dimethylformamide | HCID 6228 | — |
| Product | HCID 11318457 | HCID 11318457 | — |
Reaction Steps
After adding sodium hydride (60% dispersion in mineral oil) (179 mg, 4.47 mmol) to a solution of N-[1-[2-[1-(4-hydroxy-3-hydroxymethylbutyl)cyclohexyl]ethyl]piperidin-4-yl]-N-(5-methylpyridin-2-yl)-2-furancarboxamide (1.00 g, 2.01 mmol) in N,N-dimethylformamide (3 mL) while cooling on ice, the mixture was stirred for 40 minutes. Next, methyl iodide (0.15 mL, 2.41 mmol) was added, stirring was continued for 1 hour, and saturated aqueous sodium hydrogencarbonate (10 mL) was added. Extraction was performed with ethyl acetate, and the extract was washed with saturated aqueous sodium chloride (10 mL) and then dried over anhydrous magnesium sulfate. The residue obtained after filtering and concentration under reduced pressure was purified by silica gel column chromatography (150 g NH silica Chromatorex DM2035, hexane:ethyl acetate=1:1-chloroform:methanol=8:2) to obtain the title compound (100 mg) and a furancarboxylic acid ester of N-[1-[2-[1-(4-methoxy-3-hydroxymethylbutyl)cyclohexyl]ethyl]piperidin-4-yl]-N-(5-methylpyridin-2-yl)-2-furancarboxamide (91 mg).
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| Patent number | US07601843B2 |
|---|
| Source dataset | uspto-grants-2009_10 |
|---|
| ORD ID | ord-e45ff8390401463caf0537086ff37298 |
|---|
| Source note | uspto-grants-2009_10 |
|---|